Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
Omicron globally became the predominant SARS-CoV-2 variant in late 2021. Some studies have suggested Omicron has a different replication pattern that could affect detection by rapid antigen tests. Reports in social media have promulgated oral swabs as a superior sample for detecting Omicron in the early stage of infection compared to nasal swabs.
Transitioning to Endemic COVID-19 Testing: Evidence-Based Assessment on Current and Future Rapid Antigen Test Detection
Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.
The lab of the future: How COVID-19 taught us the value of transcendent laboratory service
Join this global webinar for real-world case reports on new and breakthrough infections and practical strategies being implemented in the pediatric and adult settings that help facilitate optimal care and workflow in time sensitive care settings.
COVID-19 co-infections: best practices for rapid differential diagnosis in pediatrics and adults
On the threshold of the 2021-2022 respiratory season, this timely update centers on influenza A&B, the COVID-19 pandemic and steps healthcare systems are taking to prepare for the upcoming (and uncertain) respiratory season
The unpredictable respiratory season: influenza and COVID-19
This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.
IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing
en
Access Now
By using this site, you agree with our use of cookies.
